Stricter review of high-risk devices to support Australia's HTA assessment
This article was originally published in RAJ Devices
Executive Summary
Australia’s Therapeutic Goods Administration has been asked to introduce by 2011 more rigorous pre-market approval requirements for higher-risk devices to satisfactorily establish the safety of these products before they are assessed for cost and clinical benefits by health technology bodies1,2.